4
Changes in Ownership
AIM ImmunoTech Inc. Filed Acc 0001493152-22-034332
Options or other derivatives
- CEO & President acquired 300,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Equels Thomas K CEO & President | 2022-11-30 | Grant or award · Options | +300,000 | 300,000 | D | ||
Loading xslF345X03/ownership.xml…